BridgeMD
New treatment option for Anxiety Depression
Official title Psychiatric Outcomes of Unruptured Intracranial Aneurysms (POUIA)
ClinicalTrials.gov ID: NCT06123325
What this study is testing
- What it's testing
- The impact of cerebrovascular procedures on patients experiencing anxiety and depression is not well studied despite the high prevalence of these mental health disorders. Unruptured Intracranial aneurysms (UIAs) have a prevalence of approximately 3% and an annual risk of 1-2% in the general population.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Unruptured intracranial aneurysms (UIA)
- mRS scores between 0-1
- Observation Group: All patients with UIAs that are eligible for conservative management
- Specific locations that are not good candidates for treatment treatment, such as cavernous internal carotid artery and very distally located aneurysms
- Aneurysm size (largest dimension) is less than 4 mm
You likely can't join if
- Prior history of Subarachnoid Hemorrhage (SAH)
- Prior history of intracranial aneurysm
- Severe comorbidities that impact the mental health of the patients, such severe psychiatric disease, and chronic end stage diseases
- Traumatic, mycotic, dissecting, or fusiform aneurysms
- Patients with communication barriers (does not include foreign language), developmental disability, or psychiatric illness that prevent understanding...
- Patients with any physical disabilities or handicaps
See the full eligibility criteria
- Unruptured intracranial aneurysms (UIA)
- mRS scores between 0-1
- Observation Group: All patients with UIAs that are eligible for conservative management
- Specific locations that are not good candidates for treatment treatment, such as cavernous internal carotid artery and very distally located aneurysms
- Aneurysm size (largest dimension) is less than 4 mm
- Treatment Group: All patients with UIAs that are decided to be treated either with endovascular or microsurgical treatments due to several reasons, such as aneurysm size above 4 mm, patient's decision
- Prior history of Subarachnoid Hemorrhage (SAH)
- Prior history of intracranial aneurysm
- Severe comorbidities that impact the mental health of the patients, such severe psychiatric disease, and chronic end stage diseases
- Traumatic, mycotic, dissecting, or fusiform aneurysms
- Patients with communication barriers (does not include foreign language), developmental disability, or psychiatric illness that prevent understanding of the questions required to complete assessments
- Patients with any physical disabilities or handicaps
The study team makes the final eligibility decision.
Where it's taking place
- The Bronx, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include The Bronx, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.